DrugDashboards

Rugby Chest Congestion Relief PE

Guaifenesin/phenylephrine · GUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1 · Tablet · Oral · Rugby Laboratories

NDC 00536-1309-07 · 1 BOTTLE, PLASTIC in 1 CARTON / 30 TABLET in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0786 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Aug 2021Oct 2025$0.0786
43 price points · per EA · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

#30 count
$2.36
#90 count
$7.08

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for guaifenesin/phenylephrine (oral solid) in the next 90 days

price up 15% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin/phenylephrine (Tablet)

LabelerStrengthFirst seenLast seen
AmerisourceBergen Drug CorpGUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
CVS Pharmacy, Inc.GUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Rugby LaboratoriesGUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Topco Associates LlcGUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Valu MerchGUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LLCGUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Rugby Chest Congestion Relief PE — NDC 00536-1309-07," retrieved September 3, 2026, https://drugdashboards.com/drug/00536130907.

Free to cite with attribution — see how the data is put together.